CHU de Québec
Québec, Quebec, G1V 4G2, Canada
NCT Number: NCT01860859
This study compares three techniques of uterine closure on myometrium thickness evaluated by ultrasound six months after the primary cesarean. The three techniques include: 1) locked single layer closure; 2) double layer closure with a first continuous locked suture and a second imbricating continuous suture; 3) double layer closure with a first continuous unlocked suture of the deep portion of the myometrium avoiding the inclusion of the decidua and a second unlocked continuous suture that approximate the upper portion of the myometrium. The primary outcome is the mean myometrium thickness at the site of the uterine scar evaluated by transvaginal ultrasound at six months after cesarean.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Québec, Quebec, G1V 4G2, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months after intervention
Using transvaginal ultrasound the residual myometrium thickness at the site of the uterine scar will be measure.
Time frame: Same day of intervention: day 1
Time frame: Same day of intervention: day 1
Time frame: Same day of intervention: day 1
CHU de Quebec-Universite Laval
Other
Randomized Controlled Trial Comparing Three Techniques of Uterine Closure on the Myometrium Thickness Evaluated With Ultrasound Six Months After a Primary Cesarean
Acronym: SUTURE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04871022
Uterine Scar Defect
Tunis, La Marsa, Tunisia
View Trial Details